Tesamorelin + CJC-1295 (No DAC) + Ipamorelin – Research-Grade Triple Peptide Blend

This formulation combines three structurally distinct synthetic peptide analogs: a full-length GHRH (1–44) analog, a modified GHRH (1–29) fragment analog lacking drug affinity complex (DAC) conjugation, and a short growth hormone–releasing pentapeptide analog. Each peptide is independently synthesized and analytically characterized prior to combination into a defined multi-peptide research construct.

In laboratory research environments, this blend is utilized as a reference system for studying multi-pathway receptor interaction models, comparative peptide signaling dynamics, and structure–function relationships involving both long-chain and short-chain synthetic peptide analogs under controlled in vitro conditions.

Unlike complex biologics or intact endogenous proteins, this triple peptide formulation represents a precisely manufactured research blend suitable for mechanistic assays and exploratory biochemical studies. This material is intended strictly for laboratory research use only and is not designed for human or veterinary application.